{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:17:12Z","timestamp":1762507032601,"version":"build-2065373602"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.maturitas.2017.03.003","type":"journal-article","created":{"date-parts":[[2017,3,15]],"date-time":"2017-03-15T14:18:59Z","timestamp":1489587539000},"page":"86-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Position Statement"],"prefix":"10.1016","volume":"100","author":[{"given":"Faustino R.","family":"P\u00e9rez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iuliana","family":"Ceausu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herman","family":"Depypere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Kehoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Lambrinoudaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred","family":"Mueck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent M.","family":"Senturk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Simoncini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John C.","family":"Stevenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Stute","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Rees","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2016","series-title":"SEER Cancer Statistics Factsheets: Ovarian Cancer","author":"Surveillance","key":"10.1016\/j.maturitas.2017.03.003_bib0005"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0010","doi-asserted-by":"crossref","DOI":"10.1097\/CEJ.0000000000000302","article-title":"GRELL EUROCARE -5 Working Group. Trends in net survival from ovarian cancer in six European Latin countries: results from the SUDCAN population-based study","author":"Chirlaque","year":"2017","journal-title":"Eur. J. Cancer Prev."},{"issue":"November (11)","key":"10.1016\/j.maturitas.2017.03.003_bib0015","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/annonc\/mdw306","article-title":"Global trends and predictions in ovarian cancer mortality","volume":"27","author":"Malvezzi","year":"2016","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.maturitas.2017.03.003_bib0020","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jamaoncol.2016.4411","article-title":"Overall survival following neoadjuvant chemotherapy vs primary cytoreductive surgery in women with epithelial ovarian cancer: analysis of the national cancer database","volume":"3","author":"Rauh-Hain","year":"2017","journal-title":"JAMA Oncol."},{"issue":"July (9990)","key":"10.1016\/j.maturitas.2017.03.003_bib0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","article-title":"Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial","volume":"386","author":"Kehoe","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0030","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1200\/EDBK_160624","article-title":"Primary surgery or neoadjuvant chemotherapy in advanced ovarian cancer: the debate continues","volume":"35","author":"Leary","year":"2016","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"September (9)","key":"10.1016\/j.maturitas.2017.03.003_bib0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/09513590.2010.487611","article-title":"Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management","volume":"26","author":"P\u00e9rez-L\u00f3pez","year":"2010","journal-title":"Gynecol. Endocrinol."},{"issue":"December (12)","key":"10.1016\/j.maturitas.2017.03.003_bib0040","doi-asserted-by":"crossref","first-page":"900","DOI":"10.7326\/0003-4819-157-11-201212040-00539","article-title":"Screening for ovarian cancer: U.S. preventive services task force reaffirmation recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann. Intern. Med."},{"issue":"June (22)","key":"10.1016\/j.maturitas.2017.03.003_bib0045","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the prostate, lung, colorectal and ovarian (PLCO) cancer screening randomized controlled trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0050","series-title":"De Vita, Hellman, and Rosenberg's Cancer: Principles and Practice of Oncology","first-page":"1368","article-title":"Ovarian cancer, fallopian tube carcinoma, and peritoneal carcinoma","author":"Cannistra","year":"2011"},{"article-title":"WHO classification of tumours of female reproductive organs","year":"2014","author":"Kurman","key":"10.1016\/j.maturitas.2017.03.003_bib0055"},{"issue":"3","key":"10.1016\/j.maturitas.2017.03.003_bib0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.maturitas.2017.03.003_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","article-title":"FIGO Committee on Gynecologic Oncology Staging classification for cancer of the ovary, fallopian tube, and peritoneum","volume":"124","author":"Prat","year":"2014","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"May (2)","key":"10.1016\/j.maturitas.2017.03.003_bib0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ygyno.2015.10.022","article-title":"Primary site assignment in tubo-ovarian high-grade serous carcinoma: consensus statement on unifying practice worldwide","volume":"141","author":"Singh","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.maturitas.2017.03.003_bib0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2016.11.011","article-title":"Malignant and borderline epithelial ovarian tumors in the pediatric and adolescent population","volume":"96","author":"Nasioudis","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"10.1016\/j.maturitas.2017.03.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"October (5)","key":"10.1016\/j.maturitas.2017.03.003_bib0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/13697137.2016.1202914","article-title":"Surgical prevention of epithelial ovary cancer without oophorectomy: changing the future","volume":"19","author":"P\u00e9rez-L\u00f3pez","year":"2016","journal-title":"Climacteric"},{"issue":"March","key":"10.1016\/j.maturitas.2017.03.003_bib0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejca.2015.12.003","article-title":"Bilateral salpingectomy can reduce the risk of ovarian cancer in the general population: a meta- meta-analysis","volume":"55","author":"Yoon","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"February 6","key":"10.1016\/j.maturitas.2017.03.003_bib0100","doi-asserted-by":"crossref","first-page":"j372","DOI":"10.1136\/bmj.j372","article-title":"Removal of all ovarian tissue versus conserving ovarian tissue at time of hysterectomy in premenopausal patients with benign disease: study using routine data and data linkage","volume":"356","author":"Mytton","year":"2017","journal-title":"BMJ"},{"issue":"October (8)","key":"10.1016\/j.maturitas.2017.03.003_bib0105","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/bjc.2016.273","article-title":"Ovarian carcinoma diagnosis: the clinical impact of 15 years of change","volume":"115","author":"Kommoss","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ygyno.2016.11.019","article-title":"CONCORD Working Group: worldwide comparison of ovarian cancer survival: histological group and stage at diagnosis (CONCORD-2)","volume":"144","author":"Matz","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"April (3)","key":"10.1016\/j.maturitas.2017.03.003_bib0115","first-page":"229","article-title":"Precursors and pathogenesis of ovarian carcinoma","volume":"45","author":"Lim","year":"2013","journal-title":"Pathology (Phila.)"},{"issue":"January (1)","key":"10.1016\/j.maturitas.2017.03.003_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2017","journal-title":"Nat. Rev. Cancer"},{"issue":"11","key":"10.1016\/j.maturitas.2017.03.003_bib0125","first-page":"6725","article-title":"Long-term follow-up of borderline ovarian tumors clinical outcome and prognostic factors","volume":"34","author":"Lazarou","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.maturitas.2017.03.003_bib0130","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2012.08.027","article-title":"Histopathologic features of ovarian borderline tumors are not predictive of clinical outcome","volume":"127","author":"Avril","year":"2012","journal-title":"Gynecol. Oncol."},{"issue":"October (8)","key":"10.1016\/j.maturitas.2017.03.003_bib0135","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1002\/ijc.23724","article-title":"Borderline ovarian tumors in Sweden 1960\u20132005: trends in incidence and age at diagnosis compared to ovarian cancer","volume":"123","author":"Sk\u00edrnisd\u00f3ttir","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"April (4)","key":"10.1016\/j.maturitas.2017.03.003_bib0140","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1600-0412.2010.01060.x","article-title":"Trends in incidence of borderline ovarian tumors in Denmark 1978\u20132006","volume":"90","author":"Hannibal","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"issue":"September (9)","key":"10.1016\/j.maturitas.2017.03.003_bib0145","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0150","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2016.08.318","article-title":"Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: a nationwide population-based cohort study","volume":"143","author":"Rasmussen","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.maturitas.2017.03.003_bib0155","first-page":"759","article-title":"Screening for ovarian cancer: recommendation statement. U.S. preventive services task force","volume":"71","author":"U.S. Preventive Services Task Force","year":"2005","journal-title":"Am. Fam. Physcian"},{"issue":"July (7)","key":"10.1016\/j.maturitas.2017.03.003_bib0160","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s00439-016-1663-9","article-title":"Australian Ovarian Cancer Study., Fasching PA, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes","volume":"135","author":"Cuellar-Partida","year":"2016","journal-title":"Hum. Genet."},{"issue":"May (5)","key":"10.1016\/j.maturitas.2017.03.003_bib0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/GIM.0b013e3181d38f2f","article-title":"Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2","volume":"12","author":"Petrucelli","year":"2010","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.maturitas.2017.03.003_bib0170","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2010.05.011","article-title":"Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.maturitas.2017.03.003_bib0175","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/ijc.30476","article-title":"Differences in survival for patients with familial and sporadic cancer","volume":"140","author":"Lee","year":"2017","journal-title":"Int. J. Cancer"},{"issue":"November (11)","key":"10.1016\/j.maturitas.2017.03.003_bib0180","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaoncol.2016.1820","article-title":"Uterine cancer after risk-Reducing salpingo-oophorectomy without hysterectomy in women with BRCA mutations","volume":"2","author":"Shu","year":"2016","journal-title":"JAMA Oncol."},{"issue":"July (1)","key":"10.1016\/j.maturitas.2017.03.003_bib0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ygyno.2013.03.027","article-title":"Hereditary Breast Cancer Study Group. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study","volume":"130","author":"Segev","year":"2013","journal-title":"Gynecol. Oncol."},{"issue":"November (5)","key":"10.1016\/j.maturitas.2017.03.003_bib0190","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/cge.12313","article-title":"Preventing ovarian cancer through genetic testing: a population-based study","volume":"86","author":"Finch","year":"2014","journal-title":"Clin. Genet."},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jama.296.2.185","article-title":"Narod SA; Hereditary Ovarian Cancer Clinical Study Group Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation","volume":"296","author":"Finch","year":"2006","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.maturitas.2017.03.003_bib0200","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1200\/JCO.2007.13.9626","article-title":"Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study","volume":"26","author":"Kauff","year":"2008","journal-title":"J. Clin. Oncol."},{"issue":"December (14)","key":"10.1016\/j.maturitas.2017.03.003_bib0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12905-014-0150-5","article-title":"Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers","volume":"12","author":"Marchetti","year":"2014","journal-title":"BMC Womens Health"},{"issue":"August (2)","key":"10.1016\/j.maturitas.2017.03.003_bib0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2015.03.003","article-title":"Hereditary breast cancer: an update on risk assessment and genetic testing in 2015","volume":"213","author":"Stuckey","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"September (1)","key":"10.1016\/j.maturitas.2017.03.003_bib0215","article-title":"Bilateral oophorectomy and Breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"109","author":"Kotsopoulos","year":"2016","journal-title":"J. Natl. Cancer Inst."},{"issue":"May (6)","key":"10.1016\/j.maturitas.2017.03.003_bib0220","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.fertnstert.2013.01.109","article-title":"Hereditary Breast Cancer Study Group. Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation","volume":"99","author":"Finch","year":"2013","journal-title":"Fertil. Steril."},{"issue":"November (2)","key":"10.1016\/j.maturitas.2017.03.003_bib0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2015.07.109","article-title":"Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis","volume":"139","author":"Li","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"February 2","key":"10.1016\/j.maturitas.2017.03.003_bib0230","article-title":"Is hormone replacement therapy safe in women with a BRCA mutation? A systematic review of the contemporary literature","author":"Birrer","year":"2016","journal-title":"Am. J. Clin. Oncol."},{"issue":"September (3)","key":"10.1016\/j.maturitas.2017.03.003_bib0235","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s10689-015-9798-8","article-title":"Hereditary Breast Cancer Study Group. Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study","volume":"14","author":"Segev","year":"2015","journal-title":"Fam. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0240","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2010.03.009","article-title":"Narod SA; Hereditary Ovarian Cancer Clinical Study Group: risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation","volume":"118","author":"Vicus","year":"2010","journal-title":"Gynecol. Oncol."},{"issue":"December 19","key":"10.1016\/j.maturitas.2017.03.003_bib0245","article-title":"PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer","author":"Modi","year":"2016","journal-title":"Oncogene"},{"issue":"November (11)","key":"10.1016\/j.maturitas.2017.03.003_bib0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/prot.25105","article-title":"Structural mutation analysis of PTEN and its genotype-phenotype correlations in endometriosis and cancer","volume":"84","author":"Smith","year":"2016","journal-title":"Proteins"},{"issue":"March (2)","key":"10.1016\/j.maturitas.2017.03.003_bib0255","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3892\/mco.2014.460","article-title":"Risk-reducing surgery in hereditary gynecological cancer: clinical applications in Lynch syndrome and hereditary breast and ovarian cancer","volume":"3","author":"Adachi","year":"2015","journal-title":"Mol. Clin. Oncol."},{"issue":"January (1)","key":"10.1016\/j.maturitas.2017.03.003_bib0260","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2014.09.009","article-title":"Richardson DL; SGO Clinical Practice Committee: society of Gynecologic Oncology statement on risk assessment for inherited gynecologic cancer predispositions","volume":"136","author":"Lancaster","year":"2015","journal-title":"Gynecol. Oncol."},{"issue":"November (5)","key":"10.1016\/j.maturitas.2017.03.003_bib0265","article-title":"National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998\u20132011","volume":"213","author":"Mikhail","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/humupd\/dmp037","article-title":"Should the ovaries be removed or retained at the time of hysterectomy for benign disease?","volume":"16","author":"Hickey","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0275","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.maturitas.2017.03.003_bib0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2014.03.041","article-title":"Tubal ligation, hysterectomy, unilateral oophorectomy, and risk of ovarian cancer in the Nurses\u2019 Health Studies","volume":"102","author":"Rice","year":"2014","journal-title":"Fertil. Steril."},{"issue":"April (2)","key":"10.1016\/j.maturitas.2017.03.003_bib0285","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Ovarian Cancer Association Consortium. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.maturitas.2017.03.003_bib0290","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/humrep\/des466","article-title":"Reproductive characteristics in relation to ovarian cancer risk by histologic pathways","volume":"28","author":"Merritt","year":"2013","journal-title":"Hum. Reprod."},{"issue":"February","key":"10.1016\/j.maturitas.2017.03.003_bib0295","article-title":"Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future","volume":"23","author":"Webb","year":"2017","journal-title":"Cancer Causes Control."},{"issue":"1","key":"10.1016\/j.maturitas.2017.03.003_bib0300","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/AOG.0b013e318291c235","article-title":"Oral contraceptive pills as primary prevention for ovarian cancer: a systematic review and meta-analysis","volume":"122","author":"Havrilesky","year":"2013","journal-title":"Obstet. Gynecol."},{"issue":"9609","key":"10.1016\/j.maturitas.2017.03.003_bib0305","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23, 257 women with ovarian cancer and 87, 303 controls","volume":"371","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2008","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.maturitas.2017.03.003_bib0310","first-page":"2197","article-title":"Oral contraceptive use and impact of cumulative intake of estrogen and progestin on risk of ovarian cancer","volume":"24","author":"Faber","year":"2013","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.maturitas.2017.03.003_bib0315","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/0284186X.2016.1175660","article-title":"Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube","volume":"55","author":"Soini","year":"2016","journal-title":"Acta Oncol."},{"issue":"7","key":"10.1016\/j.maturitas.2017.03.003_bib0320","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1158\/1055-9965.EPI-16-0011","article-title":"Oral contraceptive use in relation to ovarian cancer risk in older women","volume":"25","author":"McGuire","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"December 1","key":"10.1016\/j.maturitas.2017.03.003_bib0325","article-title":"Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk","author":"Cook","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"33","key":"10.1016\/j.maturitas.2017.03.003_bib0330","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1200\/JCO.2013.48.9021","article-title":"Oral contraceptives and risk of ovarian cancer and breast cancer among high-risk women: a systematic review and meta-analysis","volume":"31","author":"Moorman","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.maturitas.2017.03.003_bib0335","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1200\/JCO.2012.45.5758","article-title":"Ovarian cancer incidence trends in relation to changing patterns of menopausal hormone therapy use in the United States","volume":"31","author":"Yang","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"May (9980)","key":"10.1016\/j.maturitas.2017.03.003_bib0340","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies","volume":"9","author":"Collaborative Group On Epidemiological Studies Of Ovarian Cancer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0345","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.maturitas.2015.02.011","article-title":"Menopausal hormone therapy and ovarian cancer: putting risk into perspective","volume":"81","author":"P\u00e9rez-L\u00f3pez","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0350","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.maturitas.2015.03.018","article-title":"Misrepresentation of the risk of ovarian cancer among women using menopausal hormones Spurious findings in a meta-analysis","volume":"81","author":"Shapiro","year":"2015","journal-title":"Maturitas"},{"issue":"October","key":"10.1016\/j.maturitas.2017.03.003_bib0355","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.maturitas.2016.07.018","article-title":"Menopausal hormone therapy in cancer survivors: a narrative review of the literature","volume":"92","author":"Kuhle","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0360","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.maturitas.2009.11.017","article-title":"Hormone replacement after gynaecological cancer","volume":"65","author":"Singh","year":"2010","journal-title":"Maturitas"},{"issue":"4","key":"10.1016\/j.maturitas.2017.03.003_bib0365","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/annonc\/mdu578","article-title":"Low-dose aspirin use and the risk of ovarian cancer in Denmark","volume":"26","author":"Baandrup","year":"2015","journal-title":"Ann. Oncol."},{"issue":"March (7)","key":"10.1016\/j.maturitas.2017.03.003_bib0370","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/bjc.2016.39","article-title":"Analgesic medication use and risk of epithelial ovarian cancer in African American women","volume":"114","author":"Peres","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.maturitas.2017.03.003_bib0375","doi-asserted-by":"crossref","first-page":"e1001200","DOI":"10.1371\/journal.pmed.1001200","article-title":"Ovarian cancer and body size: individual participant meta-analysis including 25, 157 women with ovarian cancer from 47 epidemiological studies","volume":"9","author":"Collaborative Group on Epidemiological Studies of Ovarian Cancer","year":"2012","journal-title":"PLoS Med."},{"issue":"April (8)","key":"10.1016\/j.maturitas.2017.03.003_bib0380","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1002\/ijc.29207","article-title":"Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies","volume":"136","author":"Aune","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"August (3)","key":"10.1016\/j.maturitas.2017.03.003_bib0385","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ijc.30115","article-title":"Obesity, weight gain, and ovarian cancer risk in African American women","volume":"139","author":"Bandera","year":"2016","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.maturitas.2017.03.003_bib0390","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv088","article-title":"Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies","volume":"107","author":"Keum","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"March (20)","key":"10.1016\/j.maturitas.2017.03.003_bib0395","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/ERC-12-0395","article-title":"Ovarian cancer association consortium. obesity and risk of ovarian cancer subtypes: evidence from the ovarian cancer association consortium","volume":"20","author":"Olsen","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.maturitas.2017.03.003_bib0400","first-page":"255","article-title":"Cigarette smoking and epithelial ovarian cancer by histologic type","volume":"95","author":"Marchbanks","year":"2000","journal-title":"Obstet. Gynecol."},{"issue":"3","key":"10.1016\/j.maturitas.2017.03.003_bib0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ijc.23108","article-title":"Cigarette smoking and risk of borderline and invasive epithelial ovarian cancer","volume":"122","author":"Gram","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"December 13","key":"10.1016\/j.maturitas.2017.03.003_bib0410","article-title":"Smoking and risk of ovarian cancer by histological subtypes: an analysis among 300000 Norwegian women","author":"Licaj","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"August (24)","key":"10.1016\/j.maturitas.2017.03.003_bib0415","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the ovarian cancer cohort consortium","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Oncol."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217301342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512217301342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:09:39Z","timestamp":1759914579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512217301342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":83,"alternative-id":["S0378512217301342"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.03.003","relation":{},"ISSN":["0378-5122"],"issn-type":[{"type":"print","value":"0378-5122"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Position Statement","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2017.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}